New spinal injection offers hope for stubborn back pain
NCT ID NCT07122453
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called CNTX-3001 for people with long-term, moderate to severe low back pain that hasn't gotten better with other treatments. The drug is given as a single injection into the fluid around the spinal cord. The main goal is to check if it's safe and how the body processes it, with a small group of 16 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER BACK PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neurovations
RECRUITINGNapa, California, 94558, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Weight-Loss drug ease chronic back pain? a trial investigates
- Massage therapy may speed up recovery from lower back pain in military members
- Hip weakness may reveal hidden spine problems in back pain patients
- Scientists scan brains to unlock cannabis pain relief secrets
- Can a new gauge make back pain treatment more precise?
- Could a single stem cell shot ease your aching back?